Ferumoxytol-enhanced magnetic resonance angiography for the assessment of potential kidney transplant recipients.

about

Ferumoxytol-enhanced magnetic resonance angiography for the assessment of potential kidney transplant recipients.

Item

http://www.wikidata.org/entity/Q47199588

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Ferumoxytol-enhanced magnetic ...... kidney transplant recipients.

@en

Ferumoxytol-enhanced magnetic ...... kidney transplant recipients.

@nl

type

Item

label

Ferumoxytol-enhanced magnetic ...... kidney transplant recipients.

@en

Ferumoxytol-enhanced magnetic ...... kidney transplant recipients.

@nl

prefLabel

Ferumoxytol-enhanced magnetic ...... kidney transplant recipients.

@en

Ferumoxytol-enhanced magnetic ...... kidney transplant recipients.

@nl

P1476

Ferumoxytol-enhanced magnetic ...... kidney transplant recipients.

@en

P2093

Alex T Vesey

http://www.w3.org/2001/XMLSchema#string

David B Kingsmore

http://www.w3.org/2001/XMLSchema#string

Giles Roditi

http://www.w3.org/2001/XMLSchema#string

Martin Hennessy

http://www.w3.org/2001/XMLSchema#string

Ram Kasthuri

http://www.w3.org/2001/XMLSchema#string

Sokratis Stoumpos

http://www.w3.org/2001/XMLSchema#string

P2860

Intravenous contrast material exposure is not an independent risk factor for dialysis or mortality

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

Evaluation of renal quantitative T2* changes on MRI following administration of ferumoxytol as a T2* contrast agent.

Efficacy and safety of IV ferumoxytol for adults with iron deficiency anemia previously unresponsive to or unable to tolerate oral iron

A Phase III, randomized, open-label trial of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy

Frequency of acute kidney injury following intravenous contrast medium administration: a systematic review and meta-analysis.

Risk of Acute Kidney Injury, Dialysis, and Mortality in Patients With Chronic Kidney Disease After Intravenous Contrast Material Exposure.

USPIO-enhanced MR angiography of arteriovenous fistulas in patients with renal failure.

Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material.

Comparative outcomes of predominant facility-level use of ferumoxytol versus other intravenous iron formulations in incident hemodialysis patients

P2888

s00330-017-4934-5

P304

115-123

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00330-017-4934-5

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Patrick B Mark

Aleksandra Radjenovic

P577

2017-07-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28677065

http://www.w3.org/2001/XMLSchema#string

P921

angiography

P932

5717122

http://www.w3.org/2001/XMLSchema#string